Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments

Pre-exposure prophylaxis (PrEP) against HIV infection with tenofovir/emtricitabine is proven to be effective yet uptake of this preventive measure has been difficult due to several barriers such as cost, access, and misinformation. Certain subpopulations are disproportionately affected by this probl...

Descripción completa

Detalles Bibliográficos
Autores principales: Özdener-Poyraz, Ayşe Elif, Slugocki, Malgorzata, Kalabalik-Hoganson, Julie, Han, Jayoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395680/
https://www.ncbi.nlm.nih.gov/pubmed/32801927
http://dx.doi.org/10.2147/HIV.S216024
_version_ 1783565444800577536
author Özdener-Poyraz, Ayşe Elif
Slugocki, Malgorzata
Kalabalik-Hoganson, Julie
Han, Jayoung
author_facet Özdener-Poyraz, Ayşe Elif
Slugocki, Malgorzata
Kalabalik-Hoganson, Julie
Han, Jayoung
author_sort Özdener-Poyraz, Ayşe Elif
collection PubMed
description Pre-exposure prophylaxis (PrEP) against HIV infection with tenofovir/emtricitabine is proven to be effective yet uptake of this preventive measure has been difficult due to several barriers such as cost, access, and misinformation. Certain subpopulations are disproportionately affected by this problem. Several methods have been developed to close the gap in care. New antiretroviral treatment strategies are being investigated for safety and efficacy in preventing HIV infection.
format Online
Article
Text
id pubmed-7395680
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73956802020-08-13 Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments Özdener-Poyraz, Ayşe Elif Slugocki, Malgorzata Kalabalik-Hoganson, Julie Han, Jayoung HIV AIDS (Auckl) Review Pre-exposure prophylaxis (PrEP) against HIV infection with tenofovir/emtricitabine is proven to be effective yet uptake of this preventive measure has been difficult due to several barriers such as cost, access, and misinformation. Certain subpopulations are disproportionately affected by this problem. Several methods have been developed to close the gap in care. New antiretroviral treatment strategies are being investigated for safety and efficacy in preventing HIV infection. Dove 2020-07-28 /pmc/articles/PMC7395680/ /pubmed/32801927 http://dx.doi.org/10.2147/HIV.S216024 Text en © 2020 Özdener-Poyraz et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Özdener-Poyraz, Ayşe Elif
Slugocki, Malgorzata
Kalabalik-Hoganson, Julie
Han, Jayoung
Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
title Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
title_full Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
title_fullStr Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
title_full_unstemmed Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
title_short Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
title_sort pre-exposure prophylaxis (prep) in the prevention of hiv: strategies, target populations and upcoming treatments
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395680/
https://www.ncbi.nlm.nih.gov/pubmed/32801927
http://dx.doi.org/10.2147/HIV.S216024
work_keys_str_mv AT ozdenerpoyrazayseelif preexposureprophylaxisprepinthepreventionofhivstrategiestargetpopulationsandupcomingtreatments
AT slugockimalgorzata preexposureprophylaxisprepinthepreventionofhivstrategiestargetpopulationsandupcomingtreatments
AT kalabalikhogansonjulie preexposureprophylaxisprepinthepreventionofhivstrategiestargetpopulationsandupcomingtreatments
AT hanjayoung preexposureprophylaxisprepinthepreventionofhivstrategiestargetpopulationsandupcomingtreatments

Ejemplares similares